Megace News
Introducing Strativa Pharmaceuticals - Pharmaceutical Online (press release)
Megace ES generated more than $19 million in net sales in the second quarter of 2007. Megace ES sales are currently annualizing at over $75 million. ...
Elan Announces the Johnson & Johnson Pharmaceutical Research ... - Business Wire (press release)
Megace® is a registered trademark owned by Bristol-Myers Squibb Company licensed to Par Pharmaceutical, Inc. Rapamune® is a registered trademark owned by ...
Invalidity of Par Pharma's Patents on Megestrol Acetate ... - Seeking Alpha
In the early 1990s, Bristol-Myers Squibb (BMY) developed and patented Megace, a liquid pharmaceutical composition of megestrol acetate indicated for the ...
【页面调色版 - 金融界
... 8 potential first-to-file ANDA submissions -- Terminated certain non-core assets -- 9 generic product launches -- Megace ES? sales annualizing at over ...
Introducing Strativa Pharmaceuticals - CNNMoney.com
Megace ES generated more than $19 million in net sales in the second quarter of 2007. Megace ES sales are currently annualizing at over $75 million. ...
AUSTRALIA : $15.4 million for new palliative care initiatives - TheMatureMarket.com (press release)
“We are providing funding of $9.46 million for clinical trials for six drugs – Ketorolac, Ketamine, Megace, Octreotide, and Respiradone — through the ...
Par Pharmaceutical Files Form 10-Q/A for Third Quarter of 2006 - CNNMoney.com
Sales of Megace(R) ES (megestrol acetate) oral suspension, the company's first branded product, increased 46 percent to $12.7 million in the third quarter. ...
Hana Licenses Zensana To Par, Focuses On Oncology Pipeline - BioWorld Online
... 100 generic drugs and one branded drug, the appetite stimulant Megace ES for treating the wasting conditions of anorexia and cachexia in AIDS patients. ...
Angelina Jolie & Brad Pitt Leave France in a Huff - National Ledger
To help her gain weight, the insider says that Angelina's doctor recommended vitamins, a diet of more than 1500 calories a day and a prescription for Megace ...
Par Pharmaceutical Files Form 10-Q/A for Third Quarter of 2006 - CNNMoney.com
Sales of Megace(R) ES (megestrol acetate) oral suspension, the company's first branded product, increased 46 percent to $12.7 million in the third quarter. ...
Megace RSS Feed